Edwards Lifesciences Corporation (EW), headquartered in Irvine, California, provides products and technologies for structural ...

EW saw its stock trading at around $95 in June 2022, just before the Fed started increasing rates, and it’s still trading 30% ...

Edwards Lifesciences Corp (EW) stock saw a modest uptick, ending the day at $65.37 which represents a slight increase of $0.22 or 0.34% from the prior close of $65.15. The stock opened at $64.86 and ...

Shares of Edwards Lifesciences Corp. EW inched 0.18% higher to $65.49 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.90% ...

Vanguard Group Inc made a significant addition to its portfolio by acquiring 9,018,094 shares of Edwards Lifesciences Corp ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $81.0, with a high ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Edwards Lifesciences (EW – Research Report), ...

Edwards Lifesciences (NYSE: EW), a medical technology company specializing in artificial heart valves, currently trades at $67 per share, about 50% lower than the peak level of $131 seen in December ...

Shares of Edwards Lifesciences Corp. EW inched 0.79% higher to $67.36 Monday, on what proved to be an all-around great ...

Edward Lifesciences' Critical Care divestiture bodes well for its Structural Heart portfolio. Yet, macroeconomic issues raise worry for its operations.

Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on TransMedics Group (TMDX – Research Report), Vertex ...